Clinical trial
Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer
NCT00293579 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00293579 |
|---|---|
| Title | Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer |
| Official title | A Phase II Study of Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | Pemetrexed |
| Enrollment | 5 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Feb 17, 2006 |
| Last update posted | Feb 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: